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Abstract. 
 
The activity of the cyclin-dependent kinase 1 
(Cdk1), Cdc28, inhibits the transition from anaphase to 
G1 in budding yeast. 
 
CDC28-T18V, Y19F
 
 (
 
CDC28-VF
 
), 
a mutant that lacks inhibitory phosphorylation sites, de-
lays the exit from mitosis and is hypersensitive to per-
turbations that arrest cells in mitosis. Surprisingly, this 
behavior is not due to a lack of inhibitory phosphoryla-
tion or increased kinase activity, but reﬂects reduced 
activity of the anaphase-promoting complex (APC), a 
defect shared with other mutants that lower Cdc28/Clb 
activity in mitosis. 
 
CDC28-VF
 
 has reduced Cdc20-
dependent APC activity in mitosis, but normal Hct1-
dependent APC activity in the G1 phase of the cell cy-
cle. The defect in Cdc20-dependent APC activity in 
 
CDC28-VF 
 
correlates with reduced association of 
Cdc20 with the APC. The defects of 
 
CDC28-VF 
 
suggest 
that Cdc28 activity is required to induce the metaphase 
to anaphase transition and initiate the transition from 
anaphase to G1 in budding yeast.
Key words: anaphase-promoting complex • Hct1 • 
Cdc20 • Pds1 • sister chromatid separation
 
Introduction
 
To exit mitosis, cells must accomplish two tasks: chromo-
some segregation and inactivation of complexes between
mitotic cyclins and cyclin-dependent kinase 1 (Cdk1)
 
1
 
,
known as Cdc28 in budding yeast
 
 
 
and Cdc2 in other eu-
karyotes, which allows the cell cycle to progress into G1.
Both steps require the activity of the anaphase-promoting
complex (APC) or cyclosome, a multiprotein complex that
is required for the ubiquitination of cyclin and other unsta-
ble substrates (King et al., 1995; Sudakin et al., 1995; Zach-
ariae and Nasmyth, 1996, 1999; Yanagida et al., 1999). The
activity of the APC depends on its interaction with two
WD-40 proteins, Cdc20 (Sethi et al., 1991; Sigrist et al.,
1995; Visintin et al., 1997; Lorca et al., 1998) and Hct1
(Schwab et al., 1997; Sigrist and Lehner, 1997; Visintin et
al., 1997; Yamaguchi et al., 1997; Kitamura et al., 1998).
Cdc20 initiates the metaphase to anaphase transition by
inducing ubiquitination of the anaphase inhibitor, Pds1
(Cohen-Fix et al., 1996; Funabiki et al., 1997). This reac-
 
tion causes Pds1 degradation and sister chromatid separation
(Funabiki et al., 1996; Ciosk et al., 1998). Cdc20-depen-
dent APC activity is inhibited by the spindle checkpoint,
which senses defects in chromosome attachment to the
spindle and delays the onset of anaphase until these de-
fects are corrected (Rieder et al., 1995; Fang et al., 1998a;
Hardwick, 1998; Hwang et al., 1998; Kim et al., 1998).
The second WD-40 protein, Hct1, also activates the
APC (Schwab et al., 1997; Sigrist and Lehner, 1997; Visin-
tin et al., 1997; Kramer et al., 1998). In budding yeast,
Hct1-dependent APC activity is necessary for the ubiquiti-
nation and degradation of Clb2, the major mitotic cyclin,
which causes the sudden drop in the protein kinase activity
of Cdc28 at the end of mitosis and keeps the APC active
throughout G1 (Zachariae et al., 1998; Jaspersen et al.,
1999). The activation of the Hct1-dependent APC de-
pends on the prior activation of the Cdc20/APC, and this
dependency helps ensure that the events of mitosis occur
in the proper sequence (Lim et al., 1998; Visintin et al.,
1998; Shirayama et al., 1999; Yeong et al., 2000).
In budding yeast, active Cdc28 inhibits the transition
from anaphase to G1 (Amon, 1997; Li and Cai, 1997). One
of the primary targets that Cdc28/Clb2 complexes inhibit
is Hct1. Phosphorylation of Hct1 by Cdc28/Clb complexes
prevents it from binding to and activating the APC (Zach-
ariae et al., 1998; Jaspersen et al., 1999). This inhibition is
opposed by the phosphatase Cdc14, which de-phosphor-
ylates Hct1, initiating a positive feedback loop that drives
the cell into G1 (Visintin et al., 1998; Jaspersen et al.,
1999). As Hct1 activity rises, the rate of Clb destruction in-
creases, reducing the kinase activity of Cdc28 and further
activating Hct1. The CDK inhibitor, Sic1 (Mendenhall,
1993; Donovan et al., 1994), which inhibits Cdc28/Clb
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complexes, also participates in this feedback loop, since
both its transcription and stability are inhibited by Cdc28/
Clb activity (Amon, 1997; Toyn et al., 1997; Visintin et al.,
1998).
Does Cdc28 also play a role in inducing anaphase? In
frog and clam egg extracts, activation of the APC depends
on active Cdc2/Cyclin B complexes (Felix et al., 1990;
Hershko et al., 1994; Minshull et al., 1994; Shteinberg and
Hershko, 1999). This activating role might be explained by
the finding that Cdc2/Cyclin B can phosphorylate subunits
of the APC (Patra and Dunphy, 1998; Kotani et al., 1999),
and this phosphorylation is correlated with activating the
APC and binding of Fizzy, the Cdc20 homologue in frogs
(Peters et al., 1996; Fang et al., 1998b; Kotani et al., 1998;
Shteinberg et al., 1999). In embryonic cell cycles, no Hct1
homologue is present (Sigrist and Lehner, 1997; Lorca et
al., 1998), suggesting that Cdc20-dependent APC activity
targets both Pds1 homologues and mitotic cyclins for de-
struction. In budding yeast, the inability of Cdc20 to cata-
lyze the complete destruction of mitotic cyclins means that
Hct1 or Sic1 is required for cells to exit from mitosis
(Schwab et al., 1997; Visintin et al., 1997). Since both Hct1
and Sic1 are inhibited by Cdc28, it has been difficult to ask
whether a previous step in the exit from mitosis requires
Cdc28.
Cdc28/Clb activity is also regulated by inhibitory phos-
phorylation on residues tyrosine 19, and possibly threo-
nine 18 (Amon et al., 1992; Sorger and Murray, 1992; Boo-
her et al., 1993). Tyrosine 19 is phosphorylated by Swe1
(the homologue of Wee1 in fission yeast) and dephosphor-
ylated by Mih1 (the homologue of Cdc25 in fission yeast;
Russell et al., 1989; Booher et al., 1993). Phosphorylation
on the homologous sites of fission yeast and vertebrate
Cdc2 controls the timing of entry into mitosis and also can
be induced by the checkpoints that detect unreplicated or
damaged DNA (Gould and Nurse, 1989; Enoch and
Nurse, 1990; Norbury et al., 1991; Jin et al., 1996; Rhind et
al., 1997). In budding yeast, tyrosine 19 is phosphorylated
during S-phase, but 
 
CDC28-T18A, Y19F
 
 (
 
CDC28-AF
 
)
cells respond normally to the DNA damage checkpoint
(Amon et al., 1992; Sorger and Murray, 1992). Inhibitory
phosphorylation of Cdc28 is required for the bud emer-
gence or morphogenesis checkpoint, which delays mitosis
in cells that have not budded (Lew and Reed, 1993).
Our previous work suggested that inhibitory phosphory-
lation of Cdc28 might aid in mitotic exit. 
 
cdc55
 
D
 
 cells,
which lack a B subunit of protein phosphatase 2A (PP2A;
Healy et al., 1991), are spindle checkpoint defective and
have increased phosphorylation on tyrosine 19 of Cdc28
(Minshull et al., 1996; Wang and Burke, 1997). The prema-
ture exit from mitosis in 
 
cdc55
 
D
 
 cells with damaged spin-
dles is suppressed by 
 
CDC28-T18V, Y19F 
 
(
 
CDC28-VF
 
),
suggesting that inhibitory phosphorylation of Cdc28 might
work in concert with Hct1 and Sic1 to reduce Cdc28-asso-
ciated activity at the end of mitosis.
Here, we show that this hypothesis is incorrect. Al-
though 
 
CDC28-VF
 
 has defects in leaving mitosis, these are
not due to a lack of inhibitory phosphorylation, but reflect
a second defect of 
 
CDC28-VF
 
. This defect slows the nor-
mal activation of the Cdc20-dependent APC and reveals
that Cdc28-associated activity is essential for the activa-
tion of the APC in mitosis.
 
Materials and Methods
 
Strain and Plasmid Construction
 
Table I lists the strains used in this work. All strains are derivatives of the
W303 strain background (W303-1a; Rodney Rothstein, Columbia Univer-
sity, NY). Standard genetic techniques were used to manipulate yeast
strains (Sherman et al., 1974) and standard protocols were used for DNA
manipulation (Maniatis et al., 1982). All deletions were confirmed by
PCR or by mutant phenotype. The sequences of all oligonucleotide prim-
ers used in this study are available upon request. The strains TG1 and
DH5
 
a
 
 were used for all bacterial manipulations.
The strains used for the crosses in Table II were: JM434 (
 
CDC28-VF
 
),
JM469 (
 
CDC28-V
 
), JM467 (
 
CDC28-F
 
), ADR1541 (
 
CDC28-AF
 
),
ADR2035 (
 
CDC28-F88G
 
), KH208 (
 
swe1
 
D
 
), ADR484 (
 
cdc28-1N
 
),
ADR840 (
 
cdc28-4
 
), ADR314 (
 
clb2
 
D
 
), ADR719 (
 
cdc23-1
 
), ADR1147
(
 
cdc16-1
 
), LH226 (
 
doc1-1
 
), LH125 (
 
cdc20-1
 
), ADR1435 (
 
hct1
 
D
 
), JC126
(
 
cdc5-1
 
), ADR1298 (
 
cdc13-1
 
), and K1993 (
 
cdc15-2
 
). For all crosses, at
least 22 tetrads were analyzed.
 
BAR1
 
 was deleted using pJGsst1 (a gift of Jeremy Thorner, University
of California, Berkeley, CA). 
 
PDS1-myc18 
 
strains were made using a
 
PDS1-myc18 
 
replacement plasmid (Shirayama et al., 1998). 
 
pCUP-
GFP12-lacI12,
 
 
 
lacO:TRP1 
 
and 
 
lacO:LEU2 
 
were integrated using pSB116
(Biggins et al., 1999), pAFS52, and pAFS59 (Straight et al., 1996), respec-
tively. 
 
GAL-MPS1 
 
strains were made with pAFS120 (Hardwick et al.,
1996). 
 
MAD3 
 
was deleted using pKH181 (Hardwick et al., 2000). 
 
swe1
 
D
 
strains were made by crossing JM449 (a gift of Jeremy Minshull, Maxygen,
Redwood City, CA) to the appropriate strains. 
 
MIH1 
 
was deleted using
pIP33 (a gift of Peter Sorger, Massachusetts Institute of Technology,
Cambridge, MA). 
 
CDC55 
 
was deleted using pJM6 (Minshull et al., 1996).
 
clb2
 
D
 
 strains were made by crossing K1890 (Surana et al., 1991) to the ap-
propriate strains. 
 
CDC28-F88G 
 
strains were made by crossing JAU02 (a
gift of Jeff Ubersax, University of California, San Francisco, CA) to the
appropriate strains. The 2
 
m
 
-CDC28 plasmid is EF190 (a gift of Eric Foss,
Fred Hutchinson Cancer Research Institute, Seattle, WA) and is the
 
CDC28 
 
gene cloned into pRS425 (Sikorski and Hieter, 1989). 
 
pHIS3-
GFP-TUB1 
 
was integrated using pAFS71 (a gift of Aaron Straight, Har-
vard Medical School, Boston, MA). 
 
cdc20-3
 
 strains were made by crossing
K8029 (Shirayama et al., 1998) to the appropriate strains. 
 
pGAL-PDS1-
HA 
 
strains were made by crossing RTK43 (Jaspersen et al., 1998) to the
appropriate strains.
Mutants in 
 
CDC28-VF-HA
 
, 
 
CDC28-F-HA
 
, 
 
CDC28-V-HA
 
,
 
 
 
and
 
CDC28-HA 
 
were made as described previously (Booher et al., 1993).
 
CDC28-AF-HA 
 
was made by cloning the HindIII/XhoI fragment from
pSF35 (Peter Sorger, MIT, Cambridge, MA) into pRD96 (a gift of Ray
Deshaies, California Institute of Technology, Pasadena, CA) cut with
HindIII/XhoI to create pAR155, which was used to create a 
 
CDC28-AF-
HA 
 
strain as previously described for pRD96 (Booher et al., 1993). The
 
pGAL-CDC28 
 
plasmids were made as follows: full-length 
 
CDC28-HA
 
(pAR106) was made by cutting out the 1.1-kb XhoI-HindIII fragment of
 
CDC28-VF-HA 
 
from pRD96 and replacing it with the same fragment
from pRD47. The BstBI-BamHI fragment of pRD96 or pAR106 was then
cloned into pDK20 (a gift of Doug Kellogg, University of California,
Santa Cruz, CA) cut with SmaI and BamHI, to create pAR109 (yIP
 
-
pGAL-CDC28:URA3
 
) and pAR108 (yIP
 
-pGAL-CDC28-VF:URA3
 
). The
plasmids were cut with Stu1 and integrated at the 
 
URA3 
 
locus.
 
pGAL-CLB2-
 
D
 
176 strains were made with pAR39. An EcoRI/BamHI
fragment of 
 
CLB2 
 
that lacks the first 176 amino acids was amplified by
PCR and cloned into pDK20 cut with EcoRI and BamHI to create
pAR39. The plasmid was cut with StuI for integration at the 
 
URA3 
 
locus.
 
cks1-38 
 
strains are 
 
cks1
 
D
 
::KAN
 
R 
 
covered by 
 
cks1-38 
 
integrated at
 
TRP1 
 
(pAR183). 
 
CKS1 
 
was deleted by the PCR-targeting method. Dip-
 
loid cells were transformed with a cassette containing the bacterial 
 
KAN
 
R
 
gene, which confers G418 resistance in W303. The cassette was amplified
by PCR from pFA6a-kanMX6 (Longtine et al., 1998) with
 
 
 
primers that
contain the sequences that flank the 
 
CKS1 
 
open reading frame. pAR183
(
 
cks1-38:TRP
 
)
 
 
 
was constructed by cloning an BamHI/SphI fragment from
pSE271 (Tang and Reed, 1993) into YIplac204 (Gietz and Sugino, 1988),
the resulting plasmid was cut with EcoRV and integrated into the 
 
CKS1/
cks1
 
D
 
::KAN
 
R
 
 heterozygote at the 
 
TRP1 
 
locus. The diploid was sporu-
lated, and a resulting spore, ADR1767, which is temperature sensitive,
 
TRP
 
1
 
,
 
 
 
and 
 
KAN
 
R
 
 was used to create the strains used in this study.
 
HCT1 
 
was deleted using pAR127. An EcoRI/HindIII fragment of the
 
HCT1 
 
locus was amplified by PCR and cloned into pSK(
 
2
 
) (Stratagene)
to create pAR125. An XbaI/SmaI fragment of the 
 
HIS3 
 
gene was then 
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cloned into pAR125 cut with SpeI/XmnI, to create pAR127, which re-
places the entire 
 
HCT1 
 
open reading frame with 
 
HIS3
 
. The EcoRI/NotI
fragment of pAR127 was used to transform yeast.
 
CDC20 
 
was tagged at the NH
 
2
 
 terminus. A cassette containing 12 myc
tags (pLH71) was inserted into pCM4 (Hwang et al., 1998) cut with
BsteII, to create pLH83. The resultant plasmid was cut with EcoNI and
BglII, removing the 
 
CEN-ARS
 
 sequences, blunted, and religated to create
pLH92. This plasmid was cut with BspEI for integration at the 
 
CDC20
 
 lo-
 
Table I. Strain List
 
Name
 
MAT
 
Relevant genotype* Source
 
ADR314
 
a
 
clb2
 
D
 
::LEU2
 
This study
ADR477
 
a
 
CDC28-HA:URA3 
 
This study
ADR484
 
a
 
cdc28-1N
 
This study
ADR509
 
a
 
CDC28-VF-HA:URA3 
 
This study
ADR548
 
a
 
CDC28-HA:URA3 leu2-3,112:lacO:LEU2 his3-11,15:pHIS3-GFP-lacI:HIS3 
 
This study
ADR684
 
a
 
swe1
 
D
 
::TRP1 CDC28-HA:URA3 
 
This study
ADR719
 
a
 
cdc23-1
 
This study
ADR840
 
a
 
cdc28-4
 
This study
ADR1100
 
a
 
CDC28-V-HA:URA3 swe1
 
D
 
::TRP1 ura3-1:pGAL-MPS1:URA3 
 
This study
ADR1105
 
a
 
CDC28-V-HA:URA3 ura3-1:pGAL-MPS1:URA3 
 
This study
ADR1147
 
a
 
cdc16-1
 
This study
ADR1248
 
a
 
mad3
 
D
 
::LEU2 ura3-1:pGAL-MPS1:URA3 
 
This study
ADR1252
 
a
 
CDC28-VF-HA:URA3 bar1
 
D
 
This study
ADR1298
 
a
 
cdc13-1
 
This study
ADR1314
 
a
 
mih1
 
D
 
::LEU2 CDC28-HA:URA3 
 
This study
ADR1378
 
a
 
mih1
 
D
 
::LEU2 ura3-1:GAL-MPS1:URA3 
 
This study
ADR1389 a CDC28-HA:URA3 bar1D This study
ADR1435 a hct1D::HIS3 This study
ADR1506 a CDC28-AF-HA:URA3 ura3-1:pGAL-MPS1:URA3  This study
ADR1541 a CDC28-AF-HA:URA3 This study
ADR1606 a clb2D::LEU2 ura3-1:pGAL-MPS1:URA3  This study
ADR1685 a cdc23-1 ura3-1:pGAL-CDC28-HA:URA3 trp1-1:lacO:TRP1 his3-11,15:pCUP1-GFP-lacI:HIS3 bar1D This study
ADR1687 a cdc23-1 ura3-1:pGAL-CDC28-VF-HA:URA3 trp1-1:lacO:TRP1 his3-11,15:pCUP1-GFP-lacI:HIS3 bar1D This study
ADR1736 a cdc15-2 CDC28-VF-HA:URA3 trp1-1:pGAL-PDS1-HA:TRP1 bar1D This study
ADR1743 a cdc15-2 CDC28-HA:URA3 trp1-1:pGAL-PDS1-HA:TRP1 bar1D This study
ADR1774 a cdc15-2 clb2D:LEU2 CDC28-HA:URA3 trp1-1:pGAL-PDS1-HA:TRP1 bar1D This study
ADR1783 a cdc20-3 ura3-1:pGAL-CLB2-D176:URA3 PDS1-myc18:LEU2 his3-11,15:pHIS3-GFP-TUB1:HIS3 bar1D This study
ADR1786 a hct1D::HIS3 ura3-1:pGAL-CLB2-D176:URA3 PDS1-myc18:LEU2 his3-11,15:pHIS3-GFP-TUB1:HIS3  This study
ADR1790 a cdc15-2 CDC20-myc12 CDC28-HA:URA3  This study
ADR1793 a cdc15-2 CDC20-myc12 CDC28-VF-HA:URA3  This study
ADR1857 a CDC28-VF-HA:URA3 PDS1-myc18:LEU2 trp1-1:lacO:TRP1 his3-11,15:pCUP1-GFP-lacI:HIS3 bar1D This study
ADR1859 a CDC28-HA:URA3 PDS1-myc18:LEU2 trp1-1:lacO:TRP1 his3-11,15:pCUP1-GFP-lacI:HIS3 bar1D This study
ADR1870 a ura3-1:pGAL-CLB2-D176:URA3 PDS1-myc18:LEU2 his3-11,15:pHIS3-GFP-TUB1:HIS3 bar1D This study
ADR1899 a cdc28-1N ura3-1:pGAL-MPS1:URA3  This study
ADR1901 a cdc28-4 ura3-1:pGAL-MPS1:URA3  This study
ADR1903 a cks1D::KANR trp1-1:cks1-38:TRP1 ura3-1:pGAL-MPS1:URA3  This study
ADR1921 a cdc20-3 trp1-1:pGAL-PDS1-HA:TRP1 bar1D This study
ADR1925 a cdc28-13 trp1-1:pGAL-PDS1-HA:TRP1 This study
ADR1928 a cdc28-13 hct1D::HIS3 trp1-1:pGAL-PDS1-HA:TRP1 This study
ADR1959 a CDC28-HA-VF:URA3 trp1-1:pGAL-PDS1-HA:TRP1 bar1D This study
ADR1968 a CDC28-HA:URA3 trp1-1:pGAL-PDS1-HA:TRP1 bar1D This study
ADR2034 a CDC28-F88G ura3-1:pGAL-MPS1:URA3  This study
ADR2035 a CDC28-F88G ura3-1:pGAL-MPS1:URA3  This study
JC126 a cdc5-1 Julia Charles
JM434 a CDC28-VF-HA:URA3  Jeremy Minshull
JM445 a cdc55D::HIS3 CDC28-HA:URA3  Jeremy Minshull
JM467 a CDC28-F-HA:URA3 Jeremy Minshull
JM469 a CDC28-V-HA:URA3 Jeremy Minshull
JM477 a CDC28-VF-HA:URA3 leu2-3,112:lacO:LEU2 his3-11,15:pHIS3-GFP-lacI:HIS3  Jeremy Minshull
K1993 a cdc15-2 Kim Nasmyth
KH153‡ a ura3-1:pGAL-MPS1:URA3 this study
KH181 a CDC28-VF-HA:URA3 ura3-1:pGAL-MPS1:URA3  This study
KH183 a CDC28-VF-HA:URA3 mad3D::LEU2 ura3-1:pGAL-MPS1:URA3  This study
KH204 a CDC28-F-HA:URA3 ura3-1:pGAL-MPS1:URA3  This study
KH207 a swe1D::TRP1 ura3-1:pGAL-MPS1:URA3  This study
KH208 a swe1D::TRP1 ura3-1:pGAL-MPS1:URA3  This study
LH125 a cdc20-1 Lena Hwang
LH226 a doc1-1 Lena Hwang
*All strains are isogenic to W303-1a (MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1).
‡All pGAL-MPS1 strains are derived from crosses with KH153.The Journal of Cell Biology, Volume 149, 2000 1364
cus, creating a duplication of CDC20 and CDC20-12myc marked with the
URA3 gene. This strain was grown on 5-fluoroorotic acid to select against
the URA3 gene, and the resulting colonies were screened by Western blot
for the presence of CDC20-12myc to create LHH371. This strain was
crossed to the appropriate strains to create those used in this study.
Physiology
Stock solutions of inhibitors were: 10 mg/ml alpha factor (Biosynthesis);
10 mg/ml nocodazole (Sigma-Aldrich). All stocks were stored at 2208C in
DMSO.
For microcolony assays, cells were grown to mid-log phase in yeast ex-
tract and peptone (YEP) 1 2% raffinose, spotted onto a YEP 1 2% ga-
lactose plate, and unbudded cells were picked out into a grid with a dissec-
tion needle. The number of cells in each microcolony was counted at
different times after incubation at 308C. Each bud is counted as a cell, and
the original cells that did not bud are not included in the analysis.
For serial dilution and spotting, cells were prepared in a multiwell dish
or a microtiter plate, and using a multiprong applicator, z10 ml of each
strain and its dilutions were spotted onto various plates and incubated at
either 23 or 308C.
Sister chromatid separation was visualized using a fusion of green fluo-
rescent protein (GFP) and lacI bound to repeats of lacO, which had been
integrated at specific locations on yeast chromosomes (Straight et al.,
1996). Small samples of cells were harvested at the indicated times and ei-
ther scored live, or fixed for 10 min in 3.7% paraformaldehyde at 48C, and
then washed twice in 0.1 M KPO4 pH 7.4. The cells were then mounted on
slides and viewed by fluorescence microscopy (Nikon). In all experiments,
a minimum of 200 cells were counted per time point.
The anaphase arrest of pGAL-CLB2-D176 was visualized using pHIS3-
GFP-TUB1. GFP-Tub1 was induced by transferring cells to complete syn-
thetic medium (CSM)-His 1 2% galactose 1 10 mM 3-aminotriazole for
the first 30 min after alpha factor removal. Cells were then transferred
into YEP 1 2% galactose. Spindle length was scored in living cells by flu-
orescence microscopy. The anaphase arrest of cdc15-2 was scored by fix-
ing cells for 5 min in 70% ethanol, washing in 50 mM Tris-Cl, pH 7.5, and
then resuspending in 50 mM Tris-Cl, pH 7.4, 1 1 mg/ml 49,6-diamidino-
2-phenylindole (DAPI; Molecular Probes). Cells were then mounted on
slides and viewed by fluorescence microscopy.
Immunoprecipitation and Western Blots
In experiments where only Western blots are shown, yeast extracts were
prepared by bead beating (multitube bead beater; Biospec) frozen cell
pellets in 13 SDS sample buffer (2% SDS, 80 mM Tris-Cl, pH 6.8, 10%
glycerol, 10 mM EDTA, 0.02% bromophenol blue, 1 mM Na3VO4, 1 mM
PMSF, and 5 mM NaF) and an equal volume of acid washed glass beads
(Biospec) for 1 pulse of 90 s. Samples were then normalized based on
OD600 readings of the original yeast samples taken during the time course.
We have found that this method allows even loading of the samples and
works as well as other techniques.
Yeast extracts for immunoprecipitation and Western blots were made
by bead beating frozen cell pellets in lysis buffer (100 mM NaCl, 50 mM
Tris-Cl, pH 7.5, 50 mM NaF, 50 mM Na-b-glycerophosphate, pH 7.4, 2
mM EGTA, 2 mM EDTA, 0.1% Triton X-100, 1 mM Na3VO4, 1 mM
PMSF, and leupeptin, pepstatin and chymostatin all at 1 mg/ml) and an ex-
cess of acid washed glass beads for 2 pulses of 90 s, incubating on ice for 5
min between each pulse. The resulting lysate was separated from the glass
beads and centrifuged in a microfuge at 14,000 rpm for 5 min to remove
insoluble material. Protein concentration of each lysate was determined
using Bradford reagent (0.04% Coomassie blue G-250 dissolved in 4.75%
ethanol, then mixed with 8.5% o-phosphoric acid and H2O) and samples
were normalized based on these measurements. A portion of the lysate
was mixed with an equal volume of 23 SDS sample buffer. Standard
methods were used for PAGE and protein transfer to nitrocellulose
(Schleicher and Schuell; Minshull et al., 1996). Blots were stained with
Ponceau S to confirm transfer and equal loading of samples, and then
blocked for 30 min in antibody-specific blocking buffer (see below). All
antibodies were incubated overnight at 48C or 2 h at 258C. After washing
in PBST (PBS1 0.1% Tween-20; Maniatis et al., 1982), the blots were
then incubated in HRP-conjugated anti-rabbit or anti-mouse antibodies
(Amersham Pharmacia Biotech) at a 1:5,000 dilution in PBST for 30 min
at 258C, washed again, incubated in ECL detection reagents (Amersham
Pharmacia Biotech) or Renaissance reagents (NEN Life Science
Products), using the manufacturer’s instructions, and then exposed to
X-OMAT film (Kodak).
The following antibodies were used in Western blots: 9E10 ascites
(BabCO) was used at a dilution of 1:1,000 in PBST 1 0.02% NaN3 after
blocking in 4% nonfat dried milk in PBST. Affinity-purified rabbit poly-
clonal anti-Clb2 and anti-Clb3 antibodies (Kellogg and Murray, 1995)
were used at a dilution of 1:1,200 in blocking buffer (2% BSA, PBST,
0.5M NaCl, 0.02% NaN3). Rabbit polyclonal anti-Sic1 serum (a gift of
Mike Mendenhall, University of Kentucky, Lexington, KY) was used at
1:1,000 in blocking buffer (4% nonfat dried milk, 2% BSA, PBST, 0.02%
NaN3) 1 10 mg/ml cell lysate made from sic1D cells (JM408, made with
MDMp203; a gift of Mike Mendenhall). 12CA5 ascites (BabCO) was used
at 1:1,000, rabbit polyclonal anti-Cdc16 and anti-Cdc23 (Lamb et al., 1994)
were used at 1:2,000, and anti-Cdc27 (Lamb et al., 1994) was used at
1:2,500. These four antibodies were all diluted in blocking buffer (4%
nonfat dried milk, PBST, 0.02% NaN3).
The remaining lysate was used for immunoprecipitation. 2–20 mg of ly-
sate per sample was used depending on the experiment. 0.33–3 mg of anti-
body was added to the lysate and incubated on ice for 20 min. Samples
were then centrifuged in a microfuge at 14,000 rpm for 5 min at 48C and
transferred to 10–15 ml of protein A CL-4B Sepharose beads (Sigma-
Aldrich) that had been equilibrated in lysis buffer. The beads were ro-
tated at 48C for 1–2 h. The beads were manipulated as described below.
Histone H1 Kinase Assays
For histone H1 kinase reactions, 0.33 mg of anti-Clb2 or anti-Clb3 anti-
body was used for immunoprecipitation in 1–5 mg of cell lysate. After im-
munoprecipitation, the beads were washed three times in kinase bead
buffer (500 mM NaCl, 50 mM Tris-Cl, pH 7.4, 50 mM NaF, 5 mM EGTA,
5 mM EDTA, 0.1% Triton X-100; transferring the beads to fresh tubes af-
ter the second wash) and twice in kinase buffer (80 mM Na-b-glycero-
phosphate, pH 7.4, 15 mM MgCl2, 20 mM EGTA). All washes were per-
formed on ice. Kinase reactions were performed in 15 ml of kinase buffer
containing 1 mM DTT, 25 mM ATP, 2.5 mg histone H1 (Upstate Biotech-
nology) and 1 mCi of g[32P]ATP (Amersham Pharmacia Biotech) and
were incubated for 15 min at 258C. Reactions were stopped by adding 15
ml of 23 SDS sample buffer and heating samples to 998C for 5 min. Sam-
ples were run on a 15% polyacrylamide gel, stained, and dried. Kinase
gels were quantified using a Molecular Dynamics PhosphoImager and Im-
ageQuant software.
Phosphotyrosine Detection
For antiphosphotyrosine blots, 2 mg of 12CA5 antibody was used to im-
munoprecipitate Cdc28-HA or Cdc28-VF-HA from 15–20 mg of cell ly-
Table II. Genetic Interactions of CDC28-VF
CDC28-VF CDC28-V CDC28-F CDC28-AF swe1D CDC28-F88G cdc28-1N clb2D cdc28-4
cdc23-1 sl sl sl sl 1 sl sl sl 1
cdc16-1 sl 11 1 1 1 ND ND 1
doc1-1 sl
cdc20-1 sl
hct1D sl
cdc5-1 sl
cdc13-1 1
cdc15-2 1
sl, Synthetic lethal; ND, not determined; 1, viable.Rudner et al. Cdc28 Activates Exit from Mitosis 1365
sate. The beads were washed three times in kinase bead buffer and twice
in PBS. Standard methods were used for PAGE and protein transfer to ni-
trocellulose. The blot was then blocked in P-Tyr blocking buffer (1%
BSA, 10 mM Tris-Cl, pH 7.5, 100 mM NaCl, 0.1% Tween 20) and incu-
bated overnight at 48C in blocking buffer containing an anti-P-Tyr Fab
fragment conjugated to HRP, RC20H (Transduction Laboratories), di-
luted to 1:2,500. The blot was washed five times in TBST (10 mM Tris-Cl,
pH 7.5, 100 mM NaCl, 0.1% Tween 20), incubated in SuperSignal chemi-
luminescent substrate (Pierce Chemical Co.), using the manufacturer’s in-
structions, and then exposed to X-ray film. After exposure, the blot was
stripped in an SDS-containing buffer, and reprobed with the 12CA5 anti-
body to confirm that the same amount of Cdc28 had been immunoprecipi-
tated.
APC Assay
For APC assay, 1 mg of rabbit polyclonal anti-Cdc26 antibody (Hwang
and Murray, 1997) was used to immunoprecipitate the APC from 5 mg
of cell lysate. The APC assay was conducted as previously described
(Charles et al., 1998), except that cells were lysed in the lysis buffer de-
scribed above, the beads were washed in APC bead buffer (250 mM NaCl,
50 mM Tris-Cl, pH 7.4, 50 mM NaF, 5 mM EGTA, 5 mM EDTA, 0.1%
NP-40, 1 mM DTT) three times, and then twice in QA1NaCl buffer (20
mM Tris-Cl, pH 7.6, 100 mM NaCl, 1 mM MgCl2). 25 nM of purified Hct1
(Jaspersen et al., 1999) was added to some samples during the ubiquitina-
tion reaction.
Cdc20 Binding to the APC
For Cdc20 binding experiments, 3 mg of anti-Cdc26 antibody was used to
immunoprecipitate 10–20 mg of cell lysate. After immunoprecipitation,
the beads were washed three times in Cdc20 bead buffer (200 mM NaCl,
50 mM Tris-Cl, pH 7.4, 50 mM NaF, 5 mM EGTA, 5 mM EDTA, 0.1%
NP-40, 1 mM DTT), and then twice in low salt kinase buffer (10 mM
NaCl, 20 mM Hepes-KOH, pH 7.4, 5 mM MgCl2). The immunoprecipi-
tates were then processed for Western blots as described above.
Results
CDC28-VF Impairs Mitotic Exit
Since  CDC28-VF  suppresses the checkpoint defect of
cdc55D (Minshull et al., 1996), we wondered if the CDC28-
VF mutant alone might have difficulty leaving mitosis. Fig.
1 A shows that progression through mitosis is delayed in
CDC28-VF. Wild-type and CDC28-VF cells were arrested
in G1 by the mating pheromone alpha factor and released
into the cell cycle. Once cells had budded, alpha factor was
readded to arrest cells that had completed the cycle. This
regimen allows us to look clearly at one synchronous cell
cycle. CDC28-VF cells show a 30-min delay in the degra-
dation of the anaphase inhibitor Pds1 and sister chromatid
separation. Clb2 proteolysis and the fall in Clb2-associated
kinase activity are delayed by .30 min. These delays can
be partially attributed to a 15-min delay in Clb2 accumula-
tion, but the persistence of peak levels of Clb2 for at least
60 min clearly reflects an additional defect in CDC28-VF.
In addition, mitotic entry is not delayed because short
spindles, a marker for mitotic entry, appear at the same
time in CDC28-VF and wild-type cells (data not shown).
CDC28-VF does not delay exit from G1, since the CDK
inhibitor, Sic1 (Schwob et al., 1994), disappears at the
same time (30 min) in wild-type and CDC28-VF.
Although  CDC28-VF  delays passage through mitosis,
the doubling time of CDC28-VF cells is nearly identical to
that of wild-type cells (data not shown). This apparent par-
adox can be explained by the fact that CDC28-VF cells
exit mitosis at a larger cell size than wild-type cells, and
therefore have to grow less in G1 to reach the critical cell
size needed to pass Start, the cell cycle transition that com-
mits them to replicating their DNA (Johnston et al., 1977).
Thus, the increase in time spent in mitosis is made up by a
decrease in time spent in G1.
To see if the mitotic delay in CDC28-VF is due to diffi-
culty exiting mitosis, we examined cells that were recover-
ing from activation of the spindle checkpoint. Wild-type
and CDC28-VF cells were arrested in mitosis by treating
them with nocodazole (an inhibitor of microtubule poly-
merization) for three hours and then released from this ar-
rest into fresh medium containing alpha factor to arrest
them in G1 as they left mitosis. Wild-type cells degrade
Clb2, inactivate Clb2-associated kinase, and separate their
sisters within 90 min of removing nocodazole (Fig. 1 B).
CDC28-VF cells, however, take 150–180 min to fully es-
cape from the nocodazole arrest.
Since CDC28-VF cells are delayed in exiting mitosis,
we investigated how they responded to a prolonged mi-
totic arrest caused by the spindle checkpoint. We examined
the response to overexpressing the protein kinase Mps1,
which arrests cells in mitosis by activating the checkpoint,
but does not damage the spindle (Hardwick et al., 1996).
After about eight hours, wild-type cells overcome the ar-
rest, divide, and resume proliferating. In contrast, CDC28-
VF cells overexpressing Mps1 cannot proliferate (Fig. 2
A); when individual cells are followed microscopically,
many never divide, and the remainder go through only one
or two divisions (Fig. 2 B and data not shown). The cell cy-
cle arrest and eventual lethality are completely suppressed
by the mad3D mutation, which inactivates the spindle
checkpoint (Li and Murray, 1991; Hardwick et al., 2000).
mad3D and mad3D CDC28-VF cells divide as if there were
no activation of the checkpoint. These results show that
CDC28-VF cells, unlike wild-type, cannot escape from mi-
tosis in the presence of constant stimulation of the spindle
checkpoint.  CDC28-VF cells are also sensitive to other
perturbations that activate the spindle checkpoint, includ-
ing the presence of short linear chromosomes (Wells and
Murray, 1996) and mutations that damage the spindle
(Hardwick et al., 1999). Like Mps1 overexpression in
CDC28-VF, these treatments are lethal and cause long de-
lays in mitosis (data not shown).
The Mitotic Defect of CDC28-VF Is Not Caused by a 
Lack of Inhibitory Phosphorylation
We initially observed that CDC28-VF and cdc55D have
opposite effects on the exit from mitosis, consistent with
the idea that inhibitory phosphorylation of Cdc28 aids exit
from mitosis. More careful examination reveals that the
mitotic exit defect in CDC28-VF is not due to effects on
Cdc28 phosphorylation. Fig. 3 A shows serial dilutions of a
panel of mutants, spotted onto galactose-containing plates,
which induce Mps1 overexpression, or glucose-containing
plates, which do not. swe1D cells lack the tyrosine kinase
that phosphorylates Cdc28 (Booher et al., 1993). Like
CDC28-VF cells, they have no phosphotyrosine present on
Cdc28 (Fig. 3 B), but unlike CDC28-VF or CDC28-F, they
are no more sensitive to Mps1 overexpression than wild-
type cells. Since another kinase might phosphorylate
threonine 18 in swe1D cells, we investigated the behaviorThe Journal of Cell Biology, Volume 149, 2000 1366
of swe1D CDC28-V cells, which should lack all inhibitory
phosphorylation.  swe1D CDC28-V resemble CDC28-V
cells, both being only slightly more sensitive to Mps1 over-
expression than wild-type cells. mih1D cells, which like
cdc55D cells have increased inhibitory phosphorylation on
Cdc28 (Fig. 3 B), do not have a spindle checkpoint defect
as judged by their sensitivity to Mps1 overexpression or to
microtubule depolymerizing agents (Fig. 3 A and data not
shown).
In principle, the relative insensitivity of swe1D to Mps1
overexpression could be explained by the existence of
other kinases that phosphorylate tyrosine 19 of Cdc28. We
do not believe such a kinase exists. We have never detected
phosphotyrosine on Cdc28 in swe1D or swe1D mih1D cells
(Fig. 3 B and data not shown), and mih1D cells show a 15-
min delay in entering mitosis that is completely suppressed
by deleting SWE1, suggesting that Swe1 is the only kinase
responsible for inhibiting Cdc28 (data not shown). In addi-
tion, if such a kinase existed, we would expect CDC28-AF
(Amon et al., 1992; Sorger and Murray, 1992), which sub-
stitutes alanine at position 18 of Cdc28 rather than valine,
to behave identically to CDC28-VF. However, CDC28-AF
Figure 1. CDC28-VF delays in exit from mitosis. A, Wild-type (ADR1859) and CDC28-VF (ADR1857) were grown overnight at 238C
in YPD to mid log phase, were arrested in G1 with alpha factor (1 mg/ml), and at t 5 0 the cells were released from the G1 arrest. At t 5
90, alpha factor (1.5 mg/ml) was added back to the cultures to rearrest the cells in the next G1. Left, Samples were taken at the indicated
times and processed for Western blots and histone H1 kinase assays. Right, Sister chromatid separation was scored by counting the
number of fluorescent spots (one or two) of GFP-lacI bound to 256 tandem repeats of lacO integrated at the TRP1 locus. B, Wild-type
(ADR548) and CDC28-VF (JM477) were grown overnight at 238C in YEP 1 2% glucose to log phase, were arrested in mitosis with no-
codazole (10 mg/ml) for 3 h, and at t 5 0 the cells were released from the arrest into fresh medium containing alpha factor (10 mg/ml).
Samples were taken at the indicated times and processed for Western blots and histone H1 kinase assays. Sister chromatid separation
was scored by counting the number of fluorescent spots (one or two) of GFP-lacI bound to 256 tandem repeats of lacO integrated at the
LEU2 locus.Rudner et al. Cdc28 Activates Exit from Mitosis 1367
behaves like CDC28-F, both of which are less sensitive to
Mps1 overexpression than CDC28-VF (Fig. 3 A).
We favor the idea that the T18V, Y19F substitution
causes a phosphorylation-independent defect in Cdc28.
Based on the crystal structure of human Cdk2, tyrosine 19
of Cdc28 is adjacent to the gamma phosphate of bound
ATP (De Bondt et al., 1993). Thus, CDC28-VF, and to a
lesser extent the CDC28-F and CDC28-AF mutations,
might affect ATP binding, substrate binding, catalytic ac-
tivity, or substrate specificity of Cdc28.
Mitotic Cdc28 Kinase Activity Is Required for Proper 
Response to the Spindle Checkpoint 
Because the CDC28-VF defect is not due to a lack of in-
hibitory phosphorylation, we asked if other mutations that
affect mitotic Cdc28 activity might share phenotypes with
CDC28-VF. cdc28-1N, clb2D, and cks1-38 (a mutant in
Cks1, a Cdc28-binding protein required for passage through
Start and mitosis) are all more sensitive to Mps1 over-
expression than wild-type (Fig. 4 A; Piggott et al., 1982;
Hadwiger et al., 1989; Surana et al., 1991; Tang and Reed,
1993). This phenotype is not seen in cdc28-4, a temper-
ature-sensitive allele of Cdc28 that prevents passage
through Start and is primarily defective in the G1 function
of Cdc28 (Reed, 1980).
Does a reduction in mitotic Cdc28 activity cause the
CDC28-VF phenotype? We have observed that both Clb2-
and Clb3-associated kinase activity and total Cdc28-asso-
ciated kinase activity of CDC28-VF cells is lower than
wild-type (Fig. 4 B and data not shown). This is seen both
in synchronously cycling cells (Fig. 1, Clb2-associated ki-
nase activity) and in cells arrested by the spindle check-
point (Fig. 4 B). We estimate the specific activity of a
Cdc28-VF/Clb complex is roughly half that of a wild-type
Cdc28/Clb complex. Because the difference between wild-
type and CDC28-VF is small, it is difficult to know if it is
biologically significant. However, an independent substi-
tution in the ATP binding site of Cdc28, CDC28-F88G,
has a reduced specific activity in vitro (Bishop et al., 2000)
and is as sensitive to overexpression of Mps1 as CDC28-VF
(Fig. 4 C).
The mitotic defect of CDC28-VF is semidominant. The
heterozygote CDC28/CDC28-VF has an intermediate sen-
sitivity to Mps1 overexpression (data not shown) and
overexpression of Cdc28-VF in otherwise wild-type cells
creates cells that are fully sensitive to overexpressed Mps1
(data not shown and Fig. 5). These results suggest that
Cdc28-VF is a dominant negative mutant, which competes
with the wild-type kinase for substrates, mitotic cyclins,
and Cks1. In support of this idea, multiple copies of the
CDC28 gene on a 2m plasmid suppress the lethality of
overexpressing Mps1 in a CDC28-VF strain (Fig. 4 D).
The semidominant phenotype of CDC28-VF does not re-
flect haploinsufficiency of Cdc28, since CDC28/cdc28D
diploids, which contain half as much Cdc28 as CDC28/
CDC28  diploids, do not have a phenotype like CDC28-VF
(data not shown).
CDC28-VF Is Defective in Activating the APC
Because CDC28-VF impairs the exit from mitosis, crip-
pling other pathways involved in this process might kill
CDC28-VF cells. Our inability to make double mutants
between  CDC28-VF and mutants in the APC supports this
idea (Table II). CDC28-VF is synthetically lethal in combi-
Figure 2. CDC28-VF cannot overcome a
spindle checkpoint-dependent arrest. A, Se-
rial dilution assay. All strains contain pGAL-
MPS1. Wild-type (KH153), CDC28-VF
(KH181),  mad3D (ADR1248), and CDC28-
VF mad3D (KH183) were grown overnight in
YEP 1 2% glucose to log phase and adjusted
to A600 0.35. Twofold serial dilutions of each
strain were prepared in a multiwell dish and
then spotted onto YEP 1 2% glucose (left) or
YEP 1 2% galactose (right). The plates were
incubated at 308C for 2 d. B, Microcolony as-
say. The same strains as in A were grown
overnight at 308C in YEP 1 2% raffinose to
log phase and at t 5 0, unbudded cells were
picked out onto YEP 1 2% galactose plates.
As each cell divided, the number of cells in
each microcolony were counted at the indi-
cated times. Large-budded cells were counted
as two cells and the original cells that did not
bud were not included in the analysis. Each
strain has been tested at least three times, fol-
lowing 20–30 cells of each strain in each ex-
periment. In the experiment shown, 30 cells
of each strain were followed.The Journal of Cell Biology, Volume 149, 2000 1368
nation with mutations in components of the APC (cdc23-1,
cdc16-1, apc10-1, formerly doc1-1; Lamb et al., 1994; Ir-
niger et al., 1995; Hwang and Murray, 1997) and posi-
tive regulators of the APC (cdc5-1, hct1D and cdc20-1;
Schwab et al., 1997; Visintin et al., 1997; Charles et al.,
1998; Shirayama et al., 1998). These double mutants are
inviable at all temperatures, and although the double mu-
tant spores are able to germinate, they die in microcolo-
nies of large-budded cells (data not shown), indicating a
terminal arrest in mitosis. These genetic interactions are
specific to the APC and regulators of the APC, because
two other mutants that arrest in mitosis, cdc13-1 (which
activates the DNA damage checkpoint) and cdc15-2
(which arrests cells in anaphase) are both viable in combi-
nation with CDC28-VF.
The interactions of CDC28 alleles and clb2D with Mps1
overexpression and the cdc23-1 mutant are correlated with
each other: cdc28-1N, CDC28-F88G, and clb2D are syn-
thetically lethal in combination with cdc23-1 and cannot
proliferate when overexpressing Mps1, whereas cdc28-4 is
viable in combination with cdc23-1 or Mps1 overexpres-
sion (Table II; also, see Irniger et al., 1995). CDC28-F and
CDC28-AF, which have milder phenotypes than CDC28-
VF,  are synthetically lethal with cdc23-1, but viable in
combination with cdc16-1, a weaker APC mutant (Table
II). Lastly, swe1D is viable in combination with cdc23-1
and cdc16-1 (Table II), demonstrating that Swe1 is un-
likely to have a role in promoting the exit from mitosis.
The genetic interactions between CDC28-VF and the
APC and its regulators are a mixed blessing. Although
they suggest that Cdc28 may help activate the APC, they
prevent us from examining the phenotype of a CDC28-VF
apc2 double mutant, since it is impossible to create such a
mutant. We overcame this difficulty by exploiting the fact
that overexpressing  Cdc28-VF creates cells that behave
phenotypically like CDC28-VF. This overexpression in
cdc23-1 cells at the permissive temperature of 238C is toxic
and no cells survive even a brief 1-h pulse of CDC28-
VF expression driven by the GAL1 promoter (data not
shown).
We overexpressed CDC28 and CDC28-VF in cdc23-1
cells that had been arrested by alpha factor and then re-
leased them from the arrest into fresh medium at 238C,
adding alpha factor after budding so that cells will rearrest
when they reach the next G1. Overexpression of CDC28-
VF causes a permanent large-budded arrest with high lev-
els of Clb2 and Clb3 (Fig. 5 A). Sic1 levels never rise and
Clb2-associated kinase activity never falls. Sister separa-
tion and spindle elongation are delayed by 2 h in cells ex-
pressing CDC28-VF (Fig. 5 B and data not shown). These
observations show that the induction of anaphase is de-
layed and the transition from anaphase to G1 is com-
pletely blocked in cdc23-1 CDC28-VF cells. These pheno-
types are not due to activating the spindle checkpoint
because neither mad2D nor mad2D bub2D bypass the ar-
rest (data not shown; Hoyt et al., 1991; Li and Murray,
1991; Alexandru et al., 1999). Therefore, we conclude that
CDC28-VF is defective in activating both the Cdc20-
dependent APC, which triggers anaphase, and the Hct1-
dependent APC, which completes cyclin proteolysis.
Figure 3. Changes in inhibitory phosphorylation on
Cdc28 do not affect sensitivity to the spindle check-
point. A, Serial dilutions of strains with varying
amounts of inhibitory phosphorylation on Cdc28.
All strains contain pGAL-MPS1. Wild-type
(KH153),  CDC28-VF  (KH181),  CDC28-V
(ADR1105),  CDC28-F  (KH204),  swe1D (KH207),
swe1D CDC28-V (ADR1100), CDC28-AF
(ADR1506), and mih1D (ADR1378) were grown to
saturation for 2 d in YEP 1 2% glucose at 308C, di-
luted tenfold, and fourfold serial dilutions were pre-
pared in a multiwell dish and spotted onto YEP 1
2% glucose (left) or YEP 1 2% galactose (right).
The plates were incubated at 308C for 2 d. B, Phos-
photyrosine blot. Wild-type (ADR477), CDC28-VF
(ADR509), cdc55D (JM445), swe1D (ADR684), and
mih1D (ADR1314) were grown overnight in YEP 1
2% glucose at 238C to log phase. The cells were har-
vested, lysed, and Cdc28-HA was immunoprecipi-
tated with the 12CA5 antibody. The immunoprecip-
itates were run out on a polyacrylamide gel and
probed either with a phosphotyrosine antibody
(top) or with 12CA5 (bottom).Rudner et al. Cdc28 Activates Exit from Mitosis 1369
Figure 4. Mutants with de-
fects in mitotic Cdc28 activity
resemble CDC28-VF. A, De-
fects in mitotic Cdc28 activity
are sensitive to spindle check-
point-dependent arrest. All
strains contain pGAL-
MPS1. Wild-type  (KH153),
CDC28-VF  (KH181),  cdc28-
1N  (ADR1899),  cdc28-4
(ADR1901),  clb2D (ADR-
1606), and cks1-38 (ADR-
1903) were grown to satura-
tion for 2 d in YEP 1 2%
glucose at 238C, diluted ten-
fold, and fourfold serial dilu-
tions were prepared in a mul-
tiwell dish and spotted onto
YEP 1 2% glucose (left) or
YEP 1 2% galactose (right).
The plates were incubated
at 238C for 2.5 d. B, The spe-
cific activity of Cdc28-VF is
lower than Cdc28. Wild-type
(ADR477) and CDC28-VF
(ADR509)  were grown over-
night in YEP 1 2% glucose at
238C to log phase and ar-
rested in mitosis with nocoda-
zole (10 mg/ml) for 3 h. The
cells were then harvested,
lysed, and Clb2/Cdc28 and
Clb3/Cdc28 complexes were
immunoprecipitated, and
their histone H1 kinase activ-
ity was measured. The West-
ern blot (bottom) shows that
equal amounts of Cdc28 are
precipitated in the two
strains, although the kinase
activity (top) of Cdc28-VF is
reduced relative to wild-type.
The activity of wild-type
Cdc28 is reported as 100%
for both the anti-Clb2 and
anti-Clb3 immunoprecipi-
tates. C, CDC28-F88G be-
haves like CDC28-VF. All
strains contain pGAL-MPS1.
Wild-type (KH153), CDC28-
VF  (KH181), and CDC28-
F88G  (ADR2034) were
grown to saturation for 2 d in
YEP 1 2% glucose at 308C,
diluted tenfold, and fourfold
serial dilutions were prepared
in a multiwell dish and spot-
ted onto YEP 1 2% glucose
(left) or YEP 1 2% galactose
(right). The plates were incu-
bated at 308C for 2 d. D, 2m-CDC28 suppresses CDC28-VF. All strains contain pGAL-MPS1. Wild-type (KH153) or CDC28-VF
(KH181) containing either 2m-CDC28 or an empty 2m vector were grown to saturation for 2 d in CSM-trp 1 2% glucose at 308C, diluted
fivefold, and fourfold serial dilutions were prepared in a multiwell dish and were spotted onto CSM-trp 1 2% glucose (left) or CSM-
trp 1 2% galactose (right). The plates were incubated at 308C for 2 d.The Journal of Cell Biology, Volume 149, 2000 1370
CDC28-VF Has Normal G1 Hct1-dependent
APC Activity
The failure to induce mitotic cyclin proteolysis in cdc23-1
mutants overexpressing Cdc28-VF could reflect the re-
quirement for Cdc20 activity to activate the Hct1-depen-
dent APC (Visintin et al., 1998; Shirayama et al., 1999;
Yeong et al., 2000), or it could reflect a Cdc20-indepen-
dent defect in the activity of Hct1. To distinguish between
these possibilities, we asked if CDC28-VF has normal
APC activity in G1, a time when all APC activity is Hct1-
dependent and Cdc20 is absent (Charles et al., 1998; Prinz
et al., 1998; Shirayama et al., 1998; and see below). We im-
munoprecipitated the APC from alpha factor-arrested
cells with antibodies raised against Cdc26, a nonessential
component of the APC (Hwang and Murray, 1997), and
measured its ability to ubiquitinate an iodinated fragment
of sea urchin Cyclin B in a reconstituted ubiquitination as-
say (Charles et al., 1998). We detected no differences in
APC activity in wild-type and CDC28-VF, and the activity
of immunoprecipitates from both wild-type and CDC28-
VF could be increased by adding recombinant Hct1 (Fig.
6; Jaspersen et al., 1999). In addition, we have shown that
Hct1-dependent proteolysis of Clb2 and Pds1 in G1 is nor-
mal in CDC28-VF (data not shown and Fig. 7 C). These
experiments are consistent with the idea that the CDC28-
VF mutant has no direct effect on the activity of the Hct1-
dependent APC.
Cdc28 Activates the Cdc20-dependent APC
Cdc20 is required for sister chromatid separation (Shirayama
et al., 1998). CDC28-VF shows delays in sister separation
(Figs. 1 and 5), suggesting that Cdc20-dependent APC ac-
tivity is defective in these cells. We have approached this
issue in more detail by examining the half life of Pds1, a
substrate of the Cdc20-dependent APC (Visintin et al.,
1997; Shirayama et al., 1999; Tinker-Kulberg and Morgan,
1999) during anaphase, a time when the Cdc20-dependent
APC is thought to be active (Jaspersen et al., 1998). First,
we needed to confirm that degradation of Pds1 in ana-
phase is due to Cdc20 and not Hct1. We arrested wild-
type, cdc20-3, and hct1D strains in anaphase by over-
expressing a nondegradable Clb2 (pGAL-CLB2-D176;
Surana et al., 1993). These strains also contained an
epitope-tagged form of Pds1 replacing the endogenous
gene. When all cells had reached anaphase (Fig. 7 A, t 5
0), the cultures were shifted to 378C to see if Pds1 levels
Figure 5. cdc23-1 GAL-
CDC28-VF  arrest in mitosis
at the permissive temperature
of 238C. A, cdc23-1 GAL-
CDC28  (ADR1685) and
cdc23-1 GAL-CDC28-VF
(ADR1687) were grown
overnight at 238C in YEP 1
2% raffinose to log phase, ar-
rested in G1 with alpha factor
(1 mg/ml) for 3.5 h, and at t 5
0 released from the G1 arrest
into fresh YEP 1 2% galac-
tose. After cells had budded
(t 5 2), alpha factor (1.5 g/ml)
was added back to the cul-
tures to rearrest the cells in
the next G1. Samples were
taken at the indicated times
and processed for Western
blots and histone H1 kinase
assays. B, Sister chromatid
separation was scored by
counting the number of fluo-
rescent spots (one or two) of
GFP-lacI bound to 256 tan-
dem repeats of lacO inte-
grated at the TRP1 locus.Rudner et al. Cdc28 Activates Exit from Mitosis 1371
would rise in either the cdc20-3 or hct1D strain, as an indi-
cation that Pds1 had become more stable. Pds1 levels rose
in the cdc20-3 strain, but not in the hct1D strain, showing
that the stability of Pds1 in anaphase is controlled by the
Cdc20- rather than the Hct1-dependent APC (Fig. 7 A).
We next examined the half life of Pds1 during an
anaphase arrest caused by the cdc15-2 mutation. Pds1 is
unstable during this arrest and Cdc20 is required to exit
from the arrest (Jaspersen et al., 1998; Tinker-Kulberg and
Morgan, 1999). cdc15-2, cdc15-2 CDC28-VF, and cdc15-2
clb2D cells were arrested in anaphase, an epitope-tagged
PDS1 gene driven by the GAL1 promoter was induced by
adding galactose for 1 h, and its expression was terminated
by adding glucose. The half life of Pds1 in cdc15-2 cells in
this experiment was ,15 min, but was .1.5 h in CDC28-
VF cdc15-2 and clb2D cdc15-2 cells (Fig. 7 B), showing that
the CDC28-VF and clb2D mutations compromise Cdc20-
dependent APC activity.
Earlier studies argued that Hct1 and Cdc20 were speci-
ficity factors for the APC, with Cdc20 directing the ubiq-
uitination of Pds1 and Hct1 directing that of mitotic cy-
clins (Visintin et al., 1997). The instability of Pds1 in G1
cells, which lack detectable Cdc20 (Prinz et al., 1998),
prompted us to reexamine this issue. Wild-type, CDC28-
VF, and cdc20-3 cells were arrested in G1 by alpha factor,
or in the case of hct1D, which is resistant to alpha factor
(Schwab et al., 1997), by the cdc28-13 mutation (Reed,
1980). Once arrested, wild-type, CDC28-VF, and cdc20-3
cells were shifted to 378C (for cdc28-13 and cdc28-13
hct1D, asynchronous cultures were transferred to 378C),
pGAL-PDS1 was induced by adding galactose for two
hours and then expression was shut off by adding glu-
cose. Pds1 was equally unstable in wild-type, CDC28-VF,
cdc20-3, and cdc28-13 cells, but was completely stable in
the hct1D cdc28-13 cells. This control shows that the defect
in Pds1 stability in CDC28-VF is specific to anaphase and,
together with Fig. 7 A, shows that Pds1 is targeted for de-
struction by the Cdc20-dependent APC in mitosis and by
the Hct1-dependent APC in G1. In addition, this experi-
ment reinforces the conclusion derived from in vitro ex-
periments in Fig. 6 that CDC28-VF has no defects in Hct1-
dependent APC activity in G1. Our results differ from
those of Visintin et al. (1997), who found that stability of
Pds1 in G1 is regulated by Cdc20. Their results may have
been due to incomplete alpha factor arrest of the cdc20-1
allele used in their study. Our results agree with the recent
observation that Clb2 is targeted for destruction by both
the Cdc20- and Hct1-dependent forms of the APC (Yeong
et al., 2000).
The stabilization of Pds1 in mitotic CDC28-VF cdc15-2
cells suggests that CDC28-VF is defective in the Cdc20-
dependent APC. As a first step in investigating the bio-
chemical defect of CDC28-VF, we examined the inter-
action between Cdc20 and the APC in anaphase, a time
when the Cdc20-dependent APC is active. We arrested
cdc15-2 and cdc15-2 CDC28-VF cells in anaphase, immu-
noprecipitated the APC with anti-Cdc26 antibodies, and
examined the amount of associated Cdc20. Equal amounts
of APC was immunoprecipitated from all three strains, but
in CDC28-VF cells there was less associated Cdc20 (Fig.
8), even though the total level of Cdc20 was similar in
wild-type and CDC28-VF.
Discussion
Cdc28 Activates the APC
We have shown that the CDC28-VF mutant is defective
activating the Cdc20-dependent APC. CDC28-VF cells
show a short delay in exiting mitosis, but this delay be-
Figure 6. CDC28-VF has
normal G1 APC activity.
Wild-type (ADR1389) and
CDC28-VF  (ADR1252)
were grown overnight at
308C in YEP 1 2% glucose
to log phase and arrested in
G1 with alpha factor (1 mg/
ml) for 3 h. The cells were
harvested, lysed, and the
APC was immunoprecipitated
with anti-Cdc26 antibodies.
The in vitro ubiquitination
activity of the immunopre-
cipitates was measured in the
absence or presence of added
Hct1 protein (left). The sub-
strate for the in vitro ubiqui-
tination is an iodinated
NH2-terminal fragment of
sea urchin cyclin B (CycB).
Western blotting of the im-
munoprecipitates shows that
equal amounts of Cdc16,
Cdc23, and Cdc27 are
present in the APC isolated
from wild-type and CDC28-
VF cells (right).The Journal of Cell Biology, Volume 149, 2000 1372
comes more severe when the APC is compromised by
spindle checkpoint activation or defects in the APC or its
regulators. These phenotypes allowed us to show a re-
quirement for Cdc28 in exiting mitosis. The defect in the
exit from mitosis in CDC28-VF is correlated with reduced
binding of Cdc20 to the APC and lower Cdc20-dependent
APC activity. CDC28-VF cells have normal Hct1-depen-
dent APC activity in G1, suggesting that their failure to
Figure 7. CDC28-VF cells
have a defective Cdc20-
dependent APC. A, Destruc-
tion of Pds1 in anaphase
depends on CDC20. Wild-
type (ADR1870), cdc20-3
(ADR1783), and hct1D
(ADR1786) were grown
overnight at 238C in YEP 1
2% raffinose to log phase.
The three strains contain an
epitope-tagged Pds1 (PDS1-
myc18), can overexpress a
truncated form of Clb2
(pGAL-CLB2-D176), which
will arrest cells in anaphase,
and express a GFP-tagged al-
pha tubulin (pHIS3-GFP-
TUB1), which allows the
length of the spindle to be
easily assessed by micros-
copy. Wild-type and cdc20-3
were arrested in G1 by alpha
factor (1 mg/ml) for 3.5 h, re-
leased from the G1 arrest into
YEP 1 2% galactose, and at
t 5 0, when .90% of the cells
had reached anaphase (after
5 h, as judged by spindle
length), the cultures were
shifted to 378C. hct1D, which
is resistant to alpha factor,
was shifted from YEP 1 2%
raffinose directly to YEP 1
2% galactose. Samples were
taken at the indicated times
and processed for Western
blots. B, Pds1 is stable in
anaphase in CDC28-VF and
clb2D.  cdc15-2 GAL-PDS1-
HA  (ADR1743),  cdc15-2
CDC28-VF GAL-PDS1-HA
(ADR1736), and cdc15-2
clb2D GAL-PDS1-HA
(ADR1774) were grown
overnight at 238C in YEP 1
2% raffinose to log phase and
shifted to 378C to arrest the
cells in anaphase (raf). When
.90% of the cells had
reached anaphase (after 4 h,
as judged by nuclear division,
which was scored by DAPI staining), Pds1-HA expression was induced for 1 h by the addition of galactose (to 2%), and at t 5 0 its ex-
pression was terminated by the addition of glucose (to 2%). Samples were taken at the indicated times and processed for Western blots.
Cdc28-HA is shown as a loading control. C, The Hct1-dependent APC regulates Pds1 stability in G1. CDC28-HA GAL-PDS1-HA
(ADR1968), CDC28-VF-HA GAL-PDS1-HA (ADR1959), and cdc20-3 GAL-PDS1-HA (ADR1921) were grown overnight at 238C in
YEP 1 2% raffinose to log phase and arrested in G1 with alpha factor (1 mg/ml) for 3 h at 238C, and then shifted to 378C for an addi-
tional 1 h (raf). cdc28-13 GAL-PDS1-HA (ADR1925) and cdc28-13 hct1D GAL-PDS1-HA (ADR1928) were grown overnight at 238C
in YEP 1 2% raffinose to log phase and arrested in G1 by shifting the cultures to 378C for 3.5 h. Pds1-HA expression was induced by
addition of galactose (to 2%) for 2 h, and at t 5 0 its expression was terminated by the addition of glucose (to 2%). Samples were taken
at the indicated times and processed for Western blots. Sic1 is shown as a loading control and as evidence that all cells remain arrested
in G1.Rudner et al. Cdc28 Activates Exit from Mitosis 1373
exit mitosis is the result of interrupting the chain of events
that normally leads from mitosis to G1: reduced Cdc20-
dependent APC activation prevents the activation of
Cdc14, which normally leads to activation of Hct1 and in-
creased levels of Sic1, the key steps in inactivating the mi-
totic activity of Cdc28 (Lim et al., 1998; Visintin et al.,
1998; Jaspersen et al., 1999; Shirayama et al., 1999).
Previously, it has been shown that Cdc28 inhibits exit
from mitosis. High levels of Cdc28-associated kinase activ-
ity cause arrest in anaphase (Holloway et al., 1993; Surana
et al., 1993), and inhibiting Cdc28 in mitotically arrested
cells activates the APC, driving them through cytokinesis
and into G1 (Amon, 1997; Li and Cai, 1997). These obser-
vations led to the conclusion that the major role for mi-
totic Cdc28 in regulating the APC was to inhibit the activ-
ity that drove cells out of mitosis. Our results show that
Cdc28 has different effects on APC activity at different
stages of mitosis. Cdc28/Clb activity activates the Cdc20-
dependent APC to induce the metaphase to anaphase
transition, but inhibits the Hct1-dependent APC, thus in-
hibiting cytokinesis and the transition from anaphase to
G1. This pattern of regulation helps ensure chromosome
segregation precedes cell division and allows budding
yeast to regulate these events separately, a useful feature
in an organism that specifies the site of cytokinesis long
before spindle assembly.
Cdc28 Is Required for Recovery from
Checkpoint-dependent Arrest
Proteins that were identified as members of the spindle
checkpoint have two roles in keeping cells with depoly-
merized microtubules from leaving mitosis. Six of them,
Mps1, Mad1–Mad3, Bub1, and Bub3, detect kinetochores
that are not attached to the spindle (Hoyt et al., 1991; Li
and Murray, 1991; Weiss and Winey, 1996) and prevent
sister chromatid separation by inhibiting the Cdc20-depen-
dent APC (Hwang et al., 1998; Kim et al., 1998). In con-
trast, Bub2, also identified as part of the spindle check-
point (Hoyt et al., 1991), detects an unknown lesion and
arrests cells in anaphase, probably by preventing the acti-
vation of Cdc14 (Alexandru et al., 1999; Fesquet et al.,
1999; Fraschini et al., 1999; Li, 1999). The opposition be-
tween the inhibition of the Cdc20-dependent APC by
the spindle checkpoint and activation by Cdc28 explains
why CDC28-VF cells, which are defective in activating
the Cdc20-dependent APC, have difficulty overcoming a
checkpoint-dependent arrest.
We do not know how wild-type cells eventually escape
from mitosis despite continued Mps1 overexpression, a
process that could be described as adaptation to the spin-
dle checkpoint (Rieder and Palazzo, 1992; Minn et al.,
1996; Rudner and Murray, 1996). In particular, we cannot
distinguish between constitutive mechanisms, such as sta-
bilization of mitotic cyclins leading to a slow rise in Cdc28/
Clb activity that eventually leads to APC activation, and
induced mechanisms, such as a slow process initiated by
components of the checkpoint that leads to reduced inhi-
bition of Cdc20. Although we initially thought of CDC28-
VF as an adaptation mutant (Minshull et al., 1996), we
now believe that it achieves its effect by reducing the abil-
ity of Cdc28 to activate the Cdc20-dependent APC,
whether or not the checkpoint is active. It is only when the
checkpoint is active, however, that this reduction is suffi-
cient to keep cells from leaving mitosis. This discussion
highlights a general difficulty in studying adaptation mu-
tants: the ability to overcome prolonged checkpoint-
dependent arrests appears to be sensitive to small, check-
point-independent defects in basic cell cycle machinery
(Toczyski et al., 1997).
Other Mutants Share Phenotypes with CDC28-VF
Genetic analysis of CDC28 has revealed two types of mu-
tants, those that primarily affect G1 (cdc28-4, cdc28-13;
Reed, 1980) and those that primarily affect exit from mito-
sis (CDC28-VF, cdc28-1N; Piggott et al., 1982; Surana et
al., 1991). The mitotic mutants  share phenotypes with
clb2D and cks1-38. Do these four mutants, CDC28-VF,
cdc28-1N, clb2D and cks1-38, have a common biochemical
defect? clb2D cells contain no Clb2, and therefore have re-
duced levels of mitotic Cdc28 activity (Grandin and Reed,
1993). The defects of cdc28-1N and cks1-38, which arrest
cells in mitosis, may have more to do with altering the sub-
strate specificity of Cdc28. When assayed by immunopre-
cipitation of Clb2-associated kinase, cdc28-1N strains have
similar kinase activity to wild-type, but they have no ki-
nase activity associated with Cks1-coupled beads (Surana
et al., 1991; Kaiser et al., 1999). These results suggest that
the primary defect in cdc28-1N is its failure to bind Cks1,
which has been shown in frog and clam extracts to be es-
sential for exit from mitosis and APC phosphorylation by
Cdc2/Cyclin B (Patra and Dunphy, 1996, 1998; Shteinberg
and Hershko, 1999).
Our only clue to the biochemical defect of Cdc28-VF is
that it appears to have a small reduction in its specific ac-
tivity (Fig. 4 D). We think this defect may be important
because CDC28-F88G, a mutant in the ATP binding site
of Cdc28, also has reduced specific activity (Bishop et al.,
Figure 8. Cdc20 binding to the APC is impaired in CDC28-VF.
cdc15-2 (ADR1790) and cdc15-2 CDC28-VF (ADR1793) were
grown overnight in YEP 1 2% glucose at 238C to log phase. Both
strains contain an epitope-tagged Cdc20 (CDC20-myc12). The
cultures were shifted to 378C and after .85% of the cells were ar-
rested in anaphase (4 h, as judged by nuclear division, which was
scored by DAPI staining), the cells were harvested, lysed, and the
APC immunoprecipitated with anti-Cdc26 antibodies. The
amount of Cdc20-myc12 bound to the APC was determined by
Western blotting the immunoprecipitates with the 9E10 anti-
body. Equal amounts of APC were precipitated with the anti-
Cdc26 antibodies as judged by Cdc23 levels (left) and equal
amounts of cell lysate were used in the immunoprecipitation as
judged by Cdc20-myc12 and Cdc28-HA levels (right, cell lysate).The Journal of Cell Biology, Volume 149, 2000 1374
2000), and shares phenotypes with CDC28-VF (Fig. 4 C).
The cdc28-1N and cks1-38 mutations may produce their
effects by reducing the level of the Cdc28/Clb/Cks1 com-
plexes, whereas in clb2D cells, the complexes of Cdc28
with the remaining Clb proteins may be less capable of ac-
tivating the Cdc20-dependent APC.
Although the Cdc28 activity is lower in CDC28-VF cells,
we do not think that the defect in CDC28-VF is simply due
to lower total Cdc28 activity per cell. Overexpression of
Clb2 and Clb3, which raises Cdc28 activity in cells (Stue-
land et al., 1993), does not suppress the mitotic defect of
CDC28-VF (data not shown). This result is consistent with
the idea that the specific activity per Cdc28 molecule,
not the total Cdc28 activity per cell, is critical for activat-
ing the exit from mitosis. An alternative explanation is
that the different mutants change the substrate specificity
of Cdc28, preventing phosphorylation of important mitotic
substrates.
A Cautionary Tale
Protein phosphorylation is a common way of regulating
protein activity. Mutating putative phosphorylation sites
to nonphosphorylatable residues is a widely used tech-
nique for assessing the biological function of phosphoryla-
tion of specific proteins (Li et al., 1995; Zachariae et al.,
1998; Jaspersen et al., 1999). Our analysis of CDC28-VF
shows that such mutations can have unanticipated effects
that are independent of phosphorylation.
It is difficult to tell how common such effects are. Our
observations of CDC28-VF suggest that the studies con-
ducted with the CDC28-AF, CDC28-VF, and CDC28-F
mutants in budding yeast (as well as experiments with the
corresponding mutants in Cdc2) should be reexamined to
exclude the possibility that the observed effects of these
mutants were due to phosphorylation-independent de-
fects. A simple control is to ask whether the phenotype of
the CDC28 mutants is exactly mimicked by deletion of
SWE1. If so, the conclusions of the original experiments
are secure. If not, phosphorylation-independent effects
due to mutating the inhibitory residues may contribute to
the observed phenotypes. In the general case, the ideal
control is to show that inactivating the kinase that phos-
phorylates a particular protein produces a similar effect on
the substrate’s activity as do the phosphorylation site mu-
tants.
Does Cdc28 Phosphorylate the APC?
How does Cdc28 promote anaphase? Experiments in
frogs, clams, and mammalian cell culture have all sug-
gested that phosphorylation activates the APC by modify-
ing four of its subunits: Cdc16, Cdc23, Cdc27, and Apc1
(BimE; Hershko et al., 1994; Peters et al., 1996; Kotani
et al., 1998, 1999; Patra and Dunphy, 1998). These pro-
teins are phosphorylated during mitosis and the phosphory-
lated APC has greater Cdc20-dependent activity in vitro,
whereas dephosphorylation of purified APC causes a loss
of activity (Lahav-Baratz et al., 1995; Shteinberg et al.,
1999). Studies in clams have suggested that this phosphor-
ylation is required for proper Cdc20 binding (Shteinberg
et al., 1999). In the accompanying paper (Rudner and
Murray, 2000, this issue), we show that the APC is phos-
phorylated by Cdc28 in budding yeast, and that a defect
in this phosphorylation causes reduced Cdc20-dependent
APC activity and contributes to the CDC28-VF pheno-
type.
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